Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
SARS-CoV-2, the causative agent of COVID-19, predominantly affects the respiratory tract. As a consequence, it seems intuitive to develop antiviral agents capable of targeting the virus right on its main anatomical site of replication. Ivermectin, a U.S. FDA-approved anti-parasitic drug, was origina...
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
MDPI AG
2022-07-01
|
| Цуврал: | Pharmaceutics |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.mdpi.com/1999-4923/14/7/1432 |